Clinical Trials Directory

Trials / Completed

CompletedNCT03187457

PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?"

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Danisco · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The study will assess vaginal microbiota levels before and after antibiotic treatment in females infected with Bacterial Vaginosis (BV).

Detailed description

This method validation study will endeavour to obtain evidence for: * Recruitment methodology effectiveness * The usefulness of the "Canestest" test as a screening tool * The time required for the vaginal microbiota (particularly Lactobacillus count) to return to normal after treatment of BV infection with metronidazole. * The time required for the Nugent Score to return to normal after treatment of BV infection with metronidazole.

Conditions

Interventions

TypeNameDescription
OTHERMetronidazoleWomen with Bacterial Vaginosis treated with Metronidazole for 5 days
OTHERControl: no treatmentHealthy women without Bacterial Vaginosis

Timeline

Start date
2017-09-04
Primary completion
2017-11-14
Completion
2017-11-14
First posted
2017-06-15
Last updated
2017-12-13

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03187457. Inclusion in this directory is not an endorsement.

PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?" (NCT03187457) · Clinical Trials Directory